Healthcare -
Biotechnology - NASDAQ - US
$ 1.05
2.94 %
$ 57.8 M
Market Cap
-0.59
P/E
PRLD - TOTAL CURRENT LIABILITIES
Total Current Liabilities PRLD - Prelude Therapeutics Incorporated
21.8 M
LAST VALUE
6.62%
2 YEAR CAGR
54.91%
5 YEAR CAGR
0.00%
10 YEAR CAGR